RGC - Regencell Bioscience...

photo-url-https://images.financialmodelingprep.com/symbol/RGC.png

Regencell Bioscience Holdings Limited

RGC

NASDAQ

Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.

31.6 USD

13.1 (41.46%)

Overview Profile Financial Statements Financial Ratios Chart Analysis News Corporate Actions DCF

PPE Schedule

Year

2024

2023

2022

2021

Gross PPE

226.51k

891.91k

1.46M

81.86k

Annual Depreciation

745.59k

769.69k

604.4k

26.46k

Capital Expenditure

-5.38k

-27.39k

-780.88k

Net PPE

-513.7k

149.62k

1.64M

55.41k

All figures are in USD.

All Income Statement Balance Sheet Statement Cash Flow Statement Retained Earning Schedule PPE Schedule Intangible and Goodwill Schedule

FMP

Home Terms of Service Privacy Policy Blog Careers FAQs Contact Us

API

Documentation Pricing Formulas Market Indexes

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.